On January 30, 2026, the Honorable Christina A. Snyder of the U.S. District Court for the Central District of California entered a preliminary injunction in Goglia Nutrition, LLC v. FuturHealth, Inc., et al. (Case No. 2:25-cv-08840-CAS-MAA), a case in which LTL represents Plaintiff Goglia Nutrition, the company behind the G-Plans personalized nutrition platform. The action alleges that Goglia Nutrition’s own managers secretly founded a competing company—FuturHealth—using the company’s proprietary technology, trade secrets, and customer data, and then forced the company into one-sided agreements designed to transfer its most valuable assets for a fraction of their worth.
The court’s order requires FuturHealth to remove all references to Goglia Nutrition’s proprietary metabolic typing system from its platform and backend processes within five days, and to cease offering any programs based on metabolic typing. The order also imposes a constructive trust over revenues received from shared customers and requires FuturHealth to deposit those funds into an escrow account pending resolution of the case, with ongoing monthly accounting and anti-circumvention provisions.
A preliminary injunction of this scope is a significant development, reflecting the court’s determination that Goglia Nutrition demonstrated likelihood of success or serious questions on the merits of its claims and that irreparable harm would result absent relief. LTL has since filed a Second Amended Complaint asserting nineteen causes of action, including trade secret misappropriation, fraud, copyright infringement, and breach of fiduciary duty. LTL’s Caleb Liang, David Ammons, and Kevin Kelly continue to prosecute the case aggressively on behalf of Goglia Nutrition.